Range Low Price High Price Comment
30 days $0.0511 $0.0700 Monday, 29th Apr 2024 BLPH stock ended at $0.0551. This is 0.542% less than the trading day before Friday, 26th Apr 2024. During the day the stock fluctuated 8.98% from a day low at $0.0551 to a day high of $0.0601.
90 days $0.0470 $0.0700
52 weeks $0.0290 $11.15

Historical Bellerophon Therapeutics prices

Date Open High Low Close Volume
Feb 01, 2016 $2.34 $2.44 $2.34 $2.38 12 400
Jan 29, 2016 $2.48 $2.52 $2.31 $2.31 34 000
Jan 28, 2016 $2.52 $2.57 $2.41 $2.43 3 800
Jan 27, 2016 $2.58 $2.59 $2.49 $2.49 3 300
Jan 26, 2016 $2.51 $2.62 $2.51 $2.59 6 800
Jan 25, 2016 $2.40 $2.50 $2.38 $2.49 6 300
Jan 22, 2016 $2.49 $2.49 $2.38 $2.40 3 900
Jan 21, 2016 $2.47 $2.47 $2.42 $2.46 3 000
Jan 20, 2016 $2.44 $2.44 $2.25 $2.43 11 700
Jan 19, 2016 $2.43 $2.52 $2.36 $2.52 4 300
Jan 15, 2016 $2.39 $2.50 $2.35 $2.41 13 200
Jan 14, 2016 $2.53 $2.58 $2.36 $2.45 14 700
Jan 13, 2016 $2.54 $2.93 $2.53 $2.53 22 000
Jan 12, 2016 $2.34 $2.58 $2.32 $2.52 10 700
Jan 11, 2016 $2.40 $2.81 $2.20 $2.43 54 800
Jan 08, 2016 $2.59 $2.59 $2.40 $2.46 28 400
Jan 07, 2016 $2.70 $2.75 $2.53 $2.56 34 800
Jan 06, 2016 $2.90 $2.94 $2.72 $2.72 24 600
Jan 05, 2016 $2.90 $3.00 $2.90 $2.94 5 800
Click to get the best stock tips daily for free!

About Bellerophon Therapeutics

Bellerophon Therapeutics Bellerophon Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development of products for the treatment of cardiopulmonary diseases in the United States. Its product includes INOpulse, a proprietary pulsatile nitric oxide delivery platform for the treatment of pulmonary hypertension. The company engages in the development of INOpulse that is in Phase 3 clinical trial for the treatment of pulmonary hypertension associated w... BLPH Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT